M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.383 PLN 1.06% Market Closed
Market Cap: 26m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Net Margin
Medicofarma Biotech SA

-79%
Current
-49%
Average
-0.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-79%
=
Net Income
-1.1m
/
Revenue
1.4m

Net Margin Across Competitors

Country PL
Market Cap 26m PLN
Net Margin
-79%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 207B USD
Net Margin
14%
Country US
Market Cap 174.4B USD
Net Margin
18%
Country KR
Market Cap 67.6T KRW
Net Margin
24%
Country CH
Market Cap 40.2B CHF
Net Margin
9%
Country US
Market Cap 38.4B USD
Net Margin
9%
Country US
Market Cap 38.6B USD
Net Margin
22%
Country US
Market Cap 26.7B USD
Net Margin
21%
Country US
Market Cap 24.9B USD
Net Margin
17%
Country US
Market Cap 23.3B USD
Net Margin
-36%

Profitability Report

View the profitability report to see the full profitability analysis for Medicofarma Biotech SA.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-79%
=
Net Income
-1.1m
/
Revenue
1.4m
What is the Net Margin of Medicofarma Biotech SA?

Based on Medicofarma Biotech SA's most recent financial statements, the company has Net Margin of -79%.